Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 19 11 2020
medline: 1 9 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

To compare sensitivity of specimens for COVID-19 diagnosis, we tested 151 nasopharyngeal/midturbinate swab pairs from 117 COVID-19 inpatients using reverse-transcriptase polymerase chain reaction (RT-PCR). Sensitivity was 94% for nasopharyngeal and 75% for midturbinate swabs (P = .0001). In 88 nasopharyngeal/midturbinate pairs with matched saliva, sensitivity was 86% for nasopharyngeal swabs and 88% for combined midturbinate swabs/saliva.

Identifiants

pubmed: 33203496
pii: S0899823X20013264
doi: 10.1017/ice.2020.1326
pmc: PMC7750656
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1001-1003

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Alainna J Jamal (AJ)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Sinai Health System, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.

Mohammad Mozafarihashjin (M)

Sinai Health System, Toronto, Canada.

Eric Coomes (E)

Faculty of Medicine, University of Toronto, Toronto, Canada.

Sofia Anceva-Sami (S)

Sinai Health System, Toronto, Canada.

Shiva Barati (S)

Sinai Health System, Toronto, Canada.

Gloria Crowl (G)

Sinai Health System, Toronto, Canada.

Amna Faheem (A)

Sinai Health System, Toronto, Canada.

Lubna Farooqi (L)

Sinai Health System, Toronto, Canada.

Christopher E Kandel (CE)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Sinai Health System, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.

Saman Khan (S)

Sinai Health System, Toronto, Canada.

Angel X Li (AX)

Sinai Health System, Toronto, Canada.

Henna Mistry (H)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Aimee Paterson (A)

Sinai Health System, Toronto, Canada.

Simon Plenderleith (S)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Karren Prost (K)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Susan Poutanen (S)

Sinai Health System, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.

Jeff Powis (J)

Michael Garron Hospital, Toronto, Canada.

Renée Schryer (R)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Maureen Taylor (M)

Michael Garron Hospital, Toronto, Canada.

Lily Yip (L)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Xi Zoe Zhong (XZ)

Sinai Health System, Toronto, Canada.

Allison J McGeer (AJ)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Sinai Health System, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.

Samira Mubareka (S)

Faculty of Medicine, University of Toronto, Toronto, Canada.
Sunnybrook Health Sciences Centre, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH